Animal Model: Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery

American Journal of Pathology

Volumn 158, Issue 3, 2001, Pages 1145-1160

  Sundberg, C ^a   Nagy, J A ^a   Brown, L F ^a   Feng, D ^a   Eckelhoefer, I A ^a   Manseau, E J ^a   Dvorak, A M ^a   Dvorak, H F ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR 164; VASCULOTROPIN; VIRUS VECTOR; CYTOKINE; CYTOKINE RECEPTOR; ENDOTHELIAL CELL GROWTH FACTOR; GROWTH FACTOR RECEPTOR; ISOPROTEIN; LYMPHOKINE; PROTEIN TYROSINE KINASE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ADENOVIRUS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; EDEMA; ENDOTHELIUM CELL; FEMALE; GENE TARGETING; GLIOBLASTOMA; GLOMERULOID BODY; IN SITU HYBRIDIZATION; MACROPHAGE; MOUSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; CAPILLARY PERMEABILITY; CELL DIVISION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; TIME; TRANSGENE; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CAPILLARY PERMEABILITY; CELL DIVISION; CYTOKINES; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; IN SITU HYBRIDIZATION; LYMPHOKINES; MICE; MICE, NUDE; MODELS, ANIMAL; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN ISOFORMS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CYTOKINE; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035106147     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64062-X     Document Type: Article

References (60)

1. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor
2. Glomeruloid vascular structures in glioblastoma multiforme: An immunohistochemical and ultrastructural study
3. Tumors of central neuroepithelial origin
4. Glomeruloid structures as vascular reaction in human gastrointestinal carcinoma
5. Pericardial involvement by thymomas. Entirely intrapericardial thymoma and a pericardial metastasis of thymoma with glomeruloid vascular proliferations
6. Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine
7. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
8. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes
9. Construction of adenovirus vectors through Cre-lox recombination
10. Pathogenesis of ascites tumor growth. Angiogenesis, vascular remodeling and stroma formation in the peritoneal lining
11. Procedural guide to specimen handling for the ultrastructural pathology service laboratory
12. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): Alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development
13. JC70: A new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections
14. A novel endothelial specific membrane protein is a marker of cell-cell contacts
15. The NG2 chondroitin sulfate proteoglycan: A multifunctional proteoglycan associated with immature cells
16. NG2 proteoglycan binding peptides target tumor neovasculature
17. A monoclonal antibody against alpha smooth muscle actin: A new probe for smooth muscle differentiation
18. Binding of different dimeric forms of PDGF to human fibroblasts: Evidence for two separate receptor types
19. Immunohistochemical localization of smooth muscle myosin in normal human tissues
20. Human atherosclerosis II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions
21. HHF35, a muscle actin-specific monoclonal antibody II. Reactivity in normal, reactive, and neoplastic human tissues
22. Phenotypic changes of human smooth muscle cells during development: Late expression of heavy caldesmon and calponin
23. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue
24. Major histocompatibility complex class II antigen expression in B and T cell non-Hodgkin's lymphoma
25. Basement membrane components produced by a mouse ascites teratocarcinoma TB24. Analysis with monoclonal and polyclonal antibodies
26. Mammalian tissue distribution of a large heparan sulfate proteoglycan detected by monoclonal antibodies
27. Heterogenous distribution of type IV collagen, entactin, heparan sulfate proteoglycan, and laminin among renal basement membranes as demonstrated by quantitative immunocytochemistry
28. Early mouse molar development: Cellular changes and distribution of fibronectin, laminin and type IV collagen
29. Three new E-antigenic fibrinogen fractions found in a commercial plasmin preparation
30. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas
31. Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma
32. Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: An immuno-light and immuno-electron microscopic study
33. Vascular smooth muscle hyperplasia underlies the formation of glomeruloid vascular structures of glioblastoma multiforme
34. Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms
35. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
36. Isolation of putative progenitor endothelial cells for angiogenesis
37. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
38. Evidence for circulating bone marrow-derived endothelial cells
39. Vascular endothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothelial cells
40. Growth factor effects on cells of the vascular wall: A survey
41. Microvascular pericytes express platelet-derived growth factor β-receptors in human healing wounds and colorectal adenocarcinoma
42. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate
43. Platelet-derived growth factor: A key regulator of connective tissue cells in embryogenesis and pathogenesis
44. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse
45. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF
46. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor
47. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro
48. Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes
49. Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions
50. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
51. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing
52. Stromal angiogenesis in human glioma: A role of platelet-derived endothelial cell growth factor
53. Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line
54. Microvascular pericytes contain muscle and nonmuscle actins
55. Pericytes as collagen producing cells in excessive dermal scarring
56. Recruitment of type I collagen producing cells from the microvasculature in vitro
57. Hemangiopericytoma